The Week Ahead — Barron's
By Staff Editors
Monday 11/27
The Census Bureau reports new-home sales data. Sales of newly constructed single-family homes are expected to decline to a seasonally adjusted annual rate of 700,000 in October, from 759,000 in September.
Tuesday 11/28
S&P CoreLogic releases its Case-Shiller National Home Price Index for September. Consensus calls for a 4.2% year-over-year jump, compared with a 2.2% rise in August.
Thursday, 11/30
Salesforce announces third-quarter results after the close. Wall Street expects the company to report $2.06 in earnings per share on sales of $8.7 billion. Shares are up 70% this year.
The Bureau of Labor Statistics releases the core personal-consumption expenditures price index for October. This gauge excludes volatile food and energy prices and is the Federal Reserve's preferred inflation measure. The index is forecast to rise 3.5% year over year, a decline from September's 3.7% rise.
Ulta Beauty's quarterly results, due out after the market close, will offer investors a look at how much people are spending on discretionary items in this economy. Ulta was a Barron's stock pick in February.
To subscribe to Barron's, visit http://www.barrons.com/subscribe
(END) Dow Jones Newswires
November 24, 2023 21:45 ET (02:45 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom